Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
clinical disease » tropical disease (Expand Search), clinical cases (Expand Search)
larger decrease » marked decrease (Expand Search)
Showing 1 - 20 results of 19,472 for search '(( significantly ((larger decrease) OR (greater decrease)) ) OR ( significant clinical disease ))*', query time: 0.38s Refine Results
  1. 1
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Change in Watt’s Connectedness Scale, Subscales by Treatment Group.

    Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Study CONSORT diagram.

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Change in Demoralization Scale (DSII) by Treatment Group.

    Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group.

    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Variants assigned Clinvar pathogenic clinical significance.

    Variants assigned Clinvar pathogenic clinical significance. by Anastasiia Buianova (19871022)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 11
    Larger example of stimuli with cue relevant for Task 3.

    Larger example of stimuli with cue relevant for Task 3. by Marcel F. Hinss (14675457)

    Published 2024
    Save to List
    Saved in:
  12. 12
    Distribution of significant SNVs across disease severity.

    Distribution of significant SNVs across disease severity. by Varsha Ravi (12267659)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Patterns, classification, and clinical significance of pharmacist interventions.

    Patterns, classification, and clinical significance of pharmacist interventions. by Osama Mohamed Ibrahim (12006954)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 14
    Patients’ demographics and clinical parameters.

    Patients’ demographics and clinical parameters. by Zi-Rong Chen (9227618)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5).

    Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

    Published 2025
    Save to List
    Saved in:
  16. 16
    Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5).

    Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

    Published 2025
    Save to List
    Saved in:
  17. 17
    Demographics of the study population.

    Demographics of the study population. by Sohyun Park (78358)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 18
    Table 3 -

    Table 3 - by Sohyun Park (78358)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 19
    Exposure to biologics during pregnancy does not affect placental antibody transfer of anti-SARS-CoV-2 neutralizing antibodies, but concomitant corticosteroid exposure may decrease antibody transfer.

    Exposure to biologics during pregnancy does not affect placental antibody transfer of anti-SARS-CoV-2 neutralizing antibodies, but concomitant corticosteroid exposure may decrease... by Donna E. Leet (22772478)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Expression and clinical significance of histamine receptors in pediatric AML

    Expression and clinical significance of histamine receptors in pediatric AML by Bi Zhou (10981806)

    Published 2025
    Save to List
    Saved in:

Search Tools: